Skip to content
10-Q

Quarterly Report

FINCH THERAPEUTICS GROUP, INC.

0000950170-24-096246

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 9, 2024 1.61M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.61M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.61M sh
Capex Q2 2024 · Jun 30, 2024 $0
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$9.09M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $16.04M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $25.12M
Stockholders Equity Q2 2024 · Jun 30, 2024 $14.22M
Stockholders Equity Q2 2024 · Mar 31, 2024 $19.04M
Stockholders Equity Q2 2024 · Dec 31, 2023 $22.89M
Current Liabilities Q2 2024 · Jun 30, 2024 $4.46M
Current Liabilities Q2 2024 · Dec 31, 2023 $4.08M
Total Liabilities Q2 2024 · Jun 30, 2024 $31.36M
Total Liabilities Q2 2024 · Dec 31, 2023 $32.49M
Current Assets Q2 2024 · Jun 30, 2024 $17.28M
Current Assets Q2 2024 · Dec 31, 2023 $25.85M
Total Assets Q2 2024 · Jun 30, 2024 $45.58M
Total Assets Q2 2024 · Dec 31, 2023 $55.37M
Eps Diluted Q2 2024 · Jun 30, 2024 −$3.01
Eps Diluted Q2 2024 · Jun 30, 2024 −$5.42
Eps Basic Q2 2024 · Jun 30, 2024 −$3.01
Eps Basic Q2 2024 · Jun 30, 2024 −$5.42
Sga Expense Q2 2024 · Jun 30, 2024 $6.11M
Sga Expense Q2 2024 · Jun 30, 2024 $11.27M
Rd Expense Q2 2024 · Jun 30, 2024 $0
Rd Expense Q2 2024 · Jun 30, 2024 $0
Net Income Q2 2024 · Jun 30, 2024 −$4.83M
Net Income Q2 2024 · Jun 30, 2024 −$8.71M
Net Income Q2 2024 · Mar 31, 2024 −$3.88M
Operating Income Q2 2024 · Jun 30, 2024 −$6.11M
Operating Income Q2 2024 · Jun 30, 2024 −$11.31M
Revenue Q2 2024 · Jun 30, 2024 $0
Revenue Q2 2024 · Jun 30, 2024 $0